We utilise advanced 3D-printing techniques to fabricate tissue-engineered constructs and medical devices for clinical applications. Areas of research we are focussed on include tissue engineering with a focus towards clinically relevant therapies for cardiovascular disease as well as the development of novel biofabrication technologies utilising advanced 3D printing technologies.

Tissue engineering is a rapidly emerging field seeking to repair, replace or regenerate diseased tissues or organs. The focus of our group is the smart design of scaffolds that provide an optimal 3D environment for cell growth and differentiation, rather than growing cells in a petri dish. Our lab is equipped with custom-made flow-loop bioreactors and 3D printers to allow for the manufacture and testing of biomedical devices and stimulation of cells under physiological conditions. We focus primarily on remedies for cardiovascular disease.

Heart Valves | TBAD | Aortic Stent Grafts
Wound Healing | Tendon & Ligament

We utilise various advanced manufacturing technologies to enable us to fabricate novel biomaterials for patient-specific applications. Our melt electrowriters are state of the art and we continue to push the boundaries of what the technology is capable of. We have additional state of the art bioprinters such as the REGEMAT 3D Reg4Life. See below for the various projects we are undertaking to utilise this world-class technology and ultimately help improve patient care worldwide.

Melt Electrowriting | Bioprinting